1.
AJP E. Eyeing opthalmic products: Bioequivalence assessment and drug development - Strategic considerations. AJP [Internet]. 2014 Aug. 28 [cited 2022 Aug. 20];3(2). Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/303